NewsBot
10-20-2009, 11:10 PM
HealthDay - TUESDAY, Oct. 20 (HealthDay News) -- Votrient (pazopanib) has been approved to treat advanced renal cell carcinoma, a form of kidney cancer in which cancerous cells invade the lining of small tubes in the kidney called tubules, the U.S. Food and Drug Administration said in a news release.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20091021/hl_hsn/votrientapprovedforadvancedkidneycancer)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20091021/hl_hsn/votrientapprovedforadvancedkidneycancer)
(From Yahoo Diseases)